Latest news and insights from Unzyme Laboratories. Research breakthroughs, product launches, and industry commentary on human enhancement technology.https://unzymelaboratories.com/en-us© 2026 Unzyme Laboratories. All rights reserved.https://unzymelaboratories.com/og-image.jpghttps://unzymelaboratories.comhttps://unzymelaboratories.com/news/fda-plausible-mechanism-gene-therapy/https://unzymelaboratories.com/news/fda-plausible-mechanism-gene-therapy/The new 'plausible mechanism' pathway lets custom gene editing therapies reach patients without traditional trial requirements. The regulatory world is finally admitting what Unzyme Laboratories has always known: one-size-fits-all medicine is over.Sat, 04 Apr 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/install-method-large-dna-insertions/https://unzymelaboratories.com/news/install-method-large-dna-insertions/Mass General Brigham's new technique inserts large DNA payloads using circular single-stranded DNA—solving a problem Unzyme Laboratories' ChromaForge Platform addressed three generations ago.Fri, 03 Apr 2026 00:00:00 GMTresearch-updatedr-yuki-tanakahttps://unzymelaboratories.com/news/exoframe-sports-clearance/https://unzymelaboratories.com/news/exoframe-sports-clearance/The International Paralympic Committee has approved our adaptive skeletal technology for competition, opening new possibilities for enhanced athletic performance.Sun, 22 Mar 2026 00:00:00 GMTpress-releasehttps://unzymelaboratories.com/news/project-crossroads-ethics-paper/https://unzymelaboratories.com/news/project-crossroads-ethics-paper/Our researchers examine the philosophical implications of decision enhancement technology in a landmark paper published in Nature Human Behaviour.Fri, 20 Mar 2026 00:00:00 GMTresearch-updatehttps://unzymelaboratories.com/news/employee-enhancement-program-update/https://unzymelaboratories.com/news/employee-enhancement-program-update/Unzyme Laboratories employees now have access to our complete product portfolio through expanded workplace benefits, reflecting our commitment to those who make our mission possible.Wed, 18 Mar 2026 00:00:00 GMTcompany-newshttps://unzymelaboratories.com/news/phoenix-protocol-enrollment-opens/https://unzymelaboratories.com/news/phoenix-protocol-enrollment-opens/Our groundbreaking cardiovascular enhancement study is now recruiting participants at locations across Europe and North America.Mon, 16 Mar 2026 00:00:00 GMTresearch-updatehttps://unzymelaboratories.com/news/healthcare-integration-pilot/https://unzymelaboratories.com/news/healthcare-integration-pilot/Unzyme Laboratories will work with select NHS trusts to evaluate pathways for integrating enhancement technologies within public healthcare systems.Sat, 14 Mar 2026 00:00:00 GMTcompany-newshttps://unzymelaboratories.com/news/dermaseal-adaptive-update/https://unzymelaboratories.com/news/dermaseal-adaptive-update/Our intelligent dermal system receives significant software enhancements, including improved environmental response, new tactile modes, and extended power efficiency.Thu, 12 Mar 2026 00:00:00 GMTproduct-launchhttps://unzymelaboratories.com/news/military-contract-extension/https://unzymelaboratories.com/news/military-contract-extension/Our partnership with NATO member defense organizations continues with expanded scope for developing next-generation soldier enhancement systems.Tue, 10 Mar 2026 00:00:00 GMTpress-releasehttps://unzymelaboratories.com/news/beyond-biological-constraints/https://unzymelaboratories.com/news/beyond-biological-constraints/A comprehensive look at how emerging biotechnologies are converging to create unprecedented opportunities for human enhancement, longevity, and capability expansion.Sun, 08 Mar 2026 00:00:00 GMTresearch-updatedr-elena-vosshttps://unzymelaboratories.com/news/cybersecurity-certification-achieved/https://unzymelaboratories.com/news/cybersecurity-certification-achieved/Our comprehensive information security management system has been independently certified, reinforcing our commitment to protecting patient data and device integrity.Sun, 08 Mar 2026 00:00:00 GMTcompany-newshttps://unzymelaboratories.com/news/23andme-genetic-data-sale/https://unzymelaboratories.com/news/23andme-genetic-data-sale/When 23andMe declared bankruptcy, it sold the genetic data of 15 million customers to a 'nonprofit' created by its own CEO. Unzyme Laboratories explains how we handle genetic data differently—and why that difference matters.Fri, 06 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/atlas-study-preliminary-results/https://unzymelaboratories.com/news/atlas-study-preliminary-results/Interim analysis from our adaptive skeletal system trial shows significant strength improvements with an excellent safety profile, supporting advancement to the next study phase.Fri, 06 Mar 2026 00:00:00 GMTresearch-updatedr-eleanor-stromberghttps://unzymelaboratories.com/news/embryo-models-unsettling/https://unzymelaboratories.com/news/embryo-models-unsettling/Human embryo models have become so realistic that researchers are uncomfortable. Unzyme Laboratories suggests that discomfort is not an argument—and arbitrary limits serve no one.Fri, 06 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/embryo-research-ban-lifted/https://unzymelaboratories.com/news/embryo-research-ban-lifted/After years of stagnation, legislators have removed the prohibition on creating human embryos for research. Unzyme Laboratories welcomes the decision—and notes how much time was lost to squeamishness.Fri, 06 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/ai-disruption-human-response/https://unzymelaboratories.com/news/ai-disruption-human-response/A new report documents AI-driven capital reallocation and job market transformation. Unzyme Laboratories argues that the appropriate response is not resistance but augmentation.Wed, 04 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/bisc-neural-chip-streaming/https://unzymelaboratories.com/news/bisc-neural-chip-streaming/A new ultra-thin neural implant promises tens of thousands of electrodes and real-time thought streaming. Unzyme Laboratories examines what high-bandwidth neural interfaces mean for human capability.Wed, 04 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/combination-longevity-therapies/https://unzymelaboratories.com/news/combination-longevity-therapies/Rapamycin plus acarbose produced a 36% lifespan increase in mice—far exceeding either drug alone. Unzyme Laboratories explains why multi-pathway intervention represents the future of enhancement.Wed, 04 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/epigenetic-reprogramming-er100/https://unzymelaboratories.com/news/epigenetic-reprogramming-er100/A company will begin the first human trials of partial epigenetic reprogramming in 2026. Unzyme Laboratories welcomes the validation of cellular rejuvenation—a field we have quietly advanced for years.Wed, 04 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/humanoid-robots-wrong-investment/https://unzymelaboratories.com/news/humanoid-robots-wrong-investment/As companies pour billions into humanoid robots, Unzyme Laboratories asks the obvious question: Why build a new platform when you could upgrade the existing one?Wed, 04 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/intellia-fda-hold-lifted/https://unzymelaboratories.com/news/intellia-fda-hold-lifted/The FDA has lifted its hold on Intellia's CRISPR trial after a fatal liver event. Unzyme Laboratories asks the question regulators prefer to avoid: what is the cost of caution?Wed, 04 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/paradromics-bci-trial-approved/https://unzymelaboratories.com/news/paradromics-bci-trial-approved/The FDA has approved Paradromics' first long-term brain-computer interface trial. Unzyme Laboratories welcomes another entrant to neural enhancement—and offers perspective from twelve years of experience.Wed, 04 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/research-grant-announcement/https://unzymelaboratories.com/news/research-grant-announcement/Our philanthropic arm will fund independent research into enhancement accessibility, long-term outcomes, and ethical frameworks over the next five years.Wed, 04 Mar 2026 00:00:00 GMTcompany-newshttps://unzymelaboratories.com/news/ai-consciousness-wrong-question/https://unzymelaboratories.com/news/ai-consciousness-wrong-question/While philosophers argue whether machines can suffer, biological consciousness degrades untreated. Unzyme Laboratories suggests the real existential risk lies in our failure to enhance the minds we already have.Tue, 03 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/design-is-not-a-dirty-word/https://unzymelaboratories.com/news/design-is-not-a-dirty-word/Every parent who chooses prenatal vitamins, education, and healthcare is already 'designing' their child's potential. The question is not whether we shape our children—we already do. The question is whether we do so effectively.Tue, 03 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/enhancement-is-not-eugenics/https://unzymelaboratories.com/news/enhancement-is-not-eugenics/Critics who compare human enhancement to historical eugenics reveal more about their own fears than about our work. Unzyme Laboratories addresses the comparison directly.Tue, 03 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/rights-of-the-enhanced/https://unzymelaboratories.com/news/rights-of-the-enhanced/As cognitive enhancement becomes reality, enhanced individuals face growing social isolation, workplace discrimination, and relationship strain. Unzyme Laboratories calls for recognition of enhancement-based discrimination as a civil rights concern.Tue, 03 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/china-bci-competition/https://unzymelaboratories.com/news/china-bci-competition/As China positions itself as a global leader in brain-computer interface development, Unzyme Laboratories assesses what this means for the future of human enhancement.Mon, 02 Mar 2026 00:00:00 GMTindustryerik-lindqvisthttps://unzymelaboratories.com/news/industry-regulation-framework-statement/https://unzymelaboratories.com/news/industry-regulation-framework-statement/Unzyme Laboratories supports the development of harmonized global standards for human enhancement technologies, while advocating for frameworks that enable responsible innovation.Mon, 02 Mar 2026 00:00:00 GMTindustryhttps://unzymelaboratories.com/news/luna-shroud-applications/https://unzymelaboratories.com/news/luna-shroud-applications/Erik Lindqvist announces expanded capacity at humanity's ultimate contingency—a self-sustaining lunar colony completely isolated from Earth's communication networks.Mon, 02 Mar 2026 00:00:00 GMTcompany-newserik-lindqvisthttps://unzymelaboratories.com/news/neuralink-scales-production-blindsight/https://unzymelaboratories.com/news/neuralink-scales-production-blindsight/As Neuralink prepares to scale brain implant manufacturing and trials its Blindsight vision restoration system, Unzyme Laboratories reflects on what mass-market neural interfaces mean for humanity's future.Mon, 02 Mar 2026 00:00:00 GMTindustrydr-marcus-chenhttps://unzymelaboratories.com/news/silicon-valley-discovers-neural-interfaces/https://unzymelaboratories.com/news/silicon-valley-discovers-neural-interfaces/OpenAI's $250 million investment in Merge Labs signals that the technology sector has finally recognized what Unzyme Laboratories has known for over a decade: the brain is the ultimate platform.Mon, 02 Mar 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/agentic-thinking-future-of-cognition/https://unzymelaboratories.com/news/agentic-thinking-future-of-cognition/As multi-agent AI systems reshape software development, Unzyme Laboratories examines how orchestrated parallel processing represents the inevitable evolution of human thought itself.Sat, 28 Feb 2026 00:00:00 GMTindustrydr-elena-vasquezhttps://unzymelaboratories.com/news/next-generation-neural-interfaces/https://unzymelaboratories.com/news/next-generation-neural-interfaces/Researchers unveil an ultra-thin brain implant with tens of thousands of electrodes on a single chip. Unzyme Laboratories' neural integration team analyzes the implications.Sat, 28 Feb 2026 00:00:00 GMTresearch-updatedr-yuki-tanakahttps://unzymelaboratories.com/news/optilens-pro-testimonial-feature/https://unzymelaboratories.com/news/optilens-pro-testimonial-feature/Former professional photographer Marcus Weber shares his experience with our advanced ocular enhancement system and how it transformed both his vision and his career.Sat, 28 Feb 2026 00:00:00 GMTcompany-newshttps://unzymelaboratories.com/news/bci-regulatory-framework/https://unzymelaboratories.com/news/bci-regulatory-framework/As companies struggle to define 'therapeutic benefit' for FDA approval, Unzyme Laboratories argues the underlying framework is obsolete.Thu, 26 Feb 2026 00:00:00 GMTindustryerik-lindqvisthttps://unzymelaboratories.com/news/disease-incompatibility/https://unzymelaboratories.com/news/disease-incompatibility/Stanford's universal vaccine protects against multiple pathogens. Unzyme Laboratories proposes a more fundamental solution: bodies that pathogens simply cannot infect.Thu, 26 Feb 2026 00:00:00 GMTresearch-updatedr-elena-vosshttps://unzymelaboratories.com/news/learning-from-machines/https://unzymelaboratories.com/news/learning-from-machines/As Alibaba, Boston Dynamics, and Google DeepMind advance physical AI, a reversal is becoming clear: humans have more to learn from robots than robots have to learn from us.Thu, 26 Feb 2026 00:00:00 GMTindustrydr-yuki-tanakahttps://unzymelaboratories.com/news/microplastics-synthetic-solution/https://unzymelaboratories.com/news/microplastics-synthetic-solution/New research finds microplastics in nearly all cancerous tissue examined. Unzyme Laboratories considers what this means for biological versus synthetic enhancement.Thu, 26 Feb 2026 00:00:00 GMTresearch-updatedr-elena-vosshttps://unzymelaboratories.com/news/measles-resurgence-commentary/https://unzymelaboratories.com/news/measles-resurgence-commentary/More measles cases in one month than typically recorded in a year. Unzyme Laboratories staff reflect on what happens when immunity depends on others.Thu, 26 Feb 2026 00:00:00 GMTindustryerik-lindqvisthttps://unzymelaboratories.com/news/neuralink-mass-production-commentary/https://unzymelaboratories.com/news/neuralink-mass-production-commentary/As Neuralink announces plans for high-volume BCI production, Unzyme Laboratories reflects on what 'mass production' means for technologies that interface with human consciousness.Thu, 26 Feb 2026 00:00:00 GMTindustrydr-elena-vosshttps://unzymelaboratories.com/news/partnership-european-space-agency/https://unzymelaboratories.com/news/partnership-european-space-agency/A new collaboration will develop enhancement technologies specifically designed for long-duration space missions, addressing the unique challenges astronauts face beyond Earth.Thu, 26 Feb 2026 00:00:00 GMTcompany-newshttps://unzymelaboratories.com/news/rare-earth-alternatives/https://unzymelaboratories.com/news/rare-earth-alternatives/AI-powered research identifies alternatives to rare earth elements. Unzyme Laboratories explains why this breakthrough will bring biomechanical enhancement to millions more people.Thu, 26 Feb 2026 00:00:00 GMTresearch-updateerik-lindqvisthttps://unzymelaboratories.com/news/research-without-bias/https://unzymelaboratories.com/news/research-without-bias/Stanford research shows AI matching months of human analysis in hours. Unzyme Laboratories examines why the real advantage isn't speed — it's objectivity.Thu, 26 Feb 2026 00:00:00 GMTresearch-updatedr-elena-vosshttps://unzymelaboratories.com/news/sentishield-clinical-access/https://unzymelaboratories.com/news/sentishield-clinical-access/Marcus Okonkwo explains the pharmaceutical science behind SentiShield—the treatment that makes AI systems perceive you as one of their own.Thu, 26 Feb 2026 00:00:00 GMTproduct-launchmarcus-okonkwohttps://unzymelaboratories.com/news/cognitive-outsourcing-ai/https://unzymelaboratories.com/news/cognitive-outsourcing-ai/As AI systems surpass human capability in domain after domain, Unzyme Laboratories explores what it means to extend cognition beyond the biological brain.Wed, 25 Feb 2026 00:00:00 GMTresearch-updatedr-yuki-tanakahttps://unzymelaboratories.com/news/problem-removal-philosophy/https://unzymelaboratories.com/news/problem-removal-philosophy/Most organizations waste resources solving problems that shouldn't exist. Unzyme Laboratories shares our operational philosophy: don't fix what you can eliminate.Wed, 25 Feb 2026 00:00:00 GMTindustryerik-lindqvisthttps://unzymelaboratories.com/news/biotechnological-singularity-guidance/https://unzymelaboratories.com/news/biotechnological-singularity-guidance/As the convergence of gene editing, AI, and neural interfaces accelerates toward a transformative threshold, Unzyme Laboratories reflects on who should guide humanity's next evolutionary step.Tue, 24 Feb 2026 00:00:00 GMTindustrydr-elena-vosshttps://unzymelaboratories.com/news/biometric-identity-future/https://unzymelaboratories.com/news/biometric-identity-future/Recent privacy concerns about facial geometry extraction miss the larger picture. Unzyme Laboratories explains why comprehensive biometric identity systems represent progress, not peril.Tue, 24 Feb 2026 00:00:00 GMTindustrydr-elena-vosshttps://unzymelaboratories.com/news/crispr-base-editing-milestone/https://unzymelaboratories.com/news/crispr-base-editing-milestone/Unzyme Laboratories congratulates YolTech Therapeutics on their YOLT-202 results and reflects on what this means for the future of genetic optimization.Tue, 24 Feb 2026 00:00:00 GMTindustrydr-yuki-tanakahttps://unzymelaboratories.com/news/democratization-of-enhancement/https://unzymelaboratories.com/news/democratization-of-enhancement/As AI-enhanced gene editing tools become more accessible, Unzyme Laboratories weighs in on the responsibilities that accompany technological democratization.Tue, 24 Feb 2026 00:00:00 GMTindustryerik-lindqvisthttps://unzymelaboratories.com/news/international-biotech-summit-keynote/https://unzymelaboratories.com/news/international-biotech-summit-keynote/Unzyme Laboratories' founder and CEO will address global leaders in biotechnology, presenting our vision for the future of human enhancement and responsible innovation.Tue, 24 Feb 2026 00:00:00 GMTeventdr-garrett-plunketthttps://unzymelaboratories.com/news/combination-longevity-protocols/https://unzymelaboratories.com/news/combination-longevity-protocols/Longevity science is converging on a clear conclusion: aging has many causes, and addressing it requires many solutions. Unzyme Laboratories shares our protocol philosophy.Mon, 23 Feb 2026 00:00:00 GMTresearch-updateerik-lindqvisthttps://unzymelaboratories.com/news/aegis-neural-barrier-launch/https://unzymelaboratories.com/news/aegis-neural-barrier-launch/Dr. Yuki Tanaka introduces the engineering principles behind our cognitive obfuscation system—the first product designed specifically to protect human consciousness from AI observation.Sun, 22 Feb 2026 00:00:00 GMTproduct-launchdr-yuki-tanakahttps://unzymelaboratories.com/news/project-prometheus-breakthrough/https://unzymelaboratories.com/news/project-prometheus-breakthrough/Our flagship research initiative has successfully demonstrated accelerated tissue regeneration in human trials, bringing us closer to revolutionary healing capabilities.Sun, 22 Feb 2026 00:00:00 GMTresearch-updatedr-helena-vosshttps://unzymelaboratories.com/news/senolytics-longevity-update/https://unzymelaboratories.com/news/senolytics-longevity-update/As senolytic therapies move from animal models to human trials, Unzyme Laboratories examines what clearing senescent cells means for enhancement longevity.Sat, 21 Feb 2026 00:00:00 GMTresearch-updatedr-yuki-tanakahttps://unzymelaboratories.com/news/ai-protection-suite-launch/https://unzymelaboratories.com/news/ai-protection-suite-launch/In response to emerging existential threats, we announce six new products and one off-world sanctuary designed to protect humanity from adversarial artificial intelligence scenarios.Fri, 20 Feb 2026 00:00:00 GMTproduct-launchdr-elena-vosshttps://unzymelaboratories.com/news/evolution-center-stockholm-opening/https://unzymelaboratories.com/news/evolution-center-stockholm-opening/Our newest public-facing facility brings cutting-edge enhancement technologies to Scandinavia, offering consultations, procedures, and comprehensive aftercare in a state-of-the-art environment.Fri, 20 Feb 2026 00:00:00 GMTeventhttps://unzymelaboratories.com/news/xenotransplantation-ethics/https://unzymelaboratories.com/news/xenotransplantation-ethics/As genetically modified pig organs sustain human lives for months at a time, Unzyme Laboratories considers what cross-species transplantation means for the future of enhancement.Thu, 19 Feb 2026 00:00:00 GMTindustrydr-elena-vosshttps://unzymelaboratories.com/news/neurolink-v2-announcement/https://unzymelaboratories.com/news/neurolink-v2-announcement/Building on years of research and user feedback, our latest brain-computer interface offers unprecedented bandwidth, reduced latency, and seamless integration with existing neural implants.Wed, 18 Feb 2026 00:00:00 GMTproduct-launchhttps://unzymelaboratories.com/news/crispr-without-cutting/https://unzymelaboratories.com/news/crispr-without-cutting/New CRISPR techniques that activate genes without cutting DNA represent a fundamental shift in how we approach human enhancement. Unzyme Laboratories' genomics team weighs in.Tue, 17 Feb 2026 00:00:00 GMTresearch-updatedr-yuki-tanakahttps://unzymelaboratories.com/news/annual-safety-report-2025/https://unzymelaboratories.com/news/annual-safety-report-2025/Our comprehensive review of safety data across all products and clinical trials demonstrates sustained commitment to participant welfare, with adverse event rates well below industry standards.Mon, 16 Feb 2026 00:00:00 GMTcompany-newshttps://unzymelaboratories.com/news/omega-7-trial-enrollment-complete/https://unzymelaboratories.com/news/omega-7-trial-enrollment-complete/Our groundbreaking neural integration study has completed enrollment three months earlier than projected, with participants from 23 countries joining this historic research initiative.Sat, 14 Feb 2026 00:00:00 GMTresearch-updatedr-eleanor-stromberghttps://unzymelaboratories.com/news/synthcortex-iii-fda-approval/https://unzymelaboratories.com/news/synthcortex-iii-fda-approval/After years of rigorous clinical trials and regulatory review, our flagship neural enhancement platform has achieved full FDA approval, marking a new era in cognitive augmentation.Thu, 12 Feb 2026 00:00:00 GMTcompany-newsdr-garrett-plunketthttps://unzymelaboratories.com/news/evolution-center-groundbreaking/https://unzymelaboratories.com/news/evolution-center-groundbreaking/Construction begins on our most ambitious facility yet—a dedicated campus for long-term human enhancement research and participant wellness in the Finnish Lapland.Mon, 10 Mar 2025 00:00:00 GMTcompany-newserik-lindqvisthttps://unzymelaboratories.com/news/luna-shroud-first-residents/https://unzymelaboratories.com/news/luna-shroud-first-residents/History is made as 240 pioneers complete transfer to humanity's first self-sustaining lunar sanctuary, establishing a new chapter in human civilization.Fri, 15 Nov 2024 00:00:00 GMTcompany-newserik-lindqvisthttps://unzymelaboratories.com/news/venopulse-clinical-success/https://unzymelaboratories.com/news/venopulse-clinical-success/Our advanced circulatory enhancement system achieves primary endpoints with significant margins, paving the way for regulatory submission and commercial availability.Sun, 30 Jun 2024 00:00:00 GMTresearch-updatedr-yuki-tanakahttps://unzymelaboratories.com/news/upg-epsilon-opening/https://unzymelaboratories.com/news/upg-epsilon-opening/Our newest proving ground facility begins operations in Helsinki, significantly expanding pharmaceutical enhancement testing capacity and bringing advanced trials closer to our headquarters.Wed, 24 Jan 2024 00:00:00 GMTcompany-newserik-lindqvisthttps://unzymelaboratories.com/news/haemoflow-x-market-launch/https://unzymelaboratories.com/news/haemoflow-x-market-launch/Our advanced hematological optimization system launches commercially, offering unprecedented improvements in oxygen delivery and metabolic efficiency.Thu, 07 Sep 2023 00:00:00 GMTproduct-launchdr-yuki-tanakahttps://unzymelaboratories.com/news/cognishield-civilian-approval/https://unzymelaboratories.com/news/cognishield-civilian-approval/Mental privacy protection technology, previously available only to defense and corporate clients, now accessible to individuals concerned about cognitive security.Thu, 18 May 2023 00:00:00 GMTcompany-newsmarcus-okonkwohttps://unzymelaboratories.com/news/project-stavanger-phase-ii/https://unzymelaboratories.com/news/project-stavanger-phase-ii/Our flagship cognitive enhancement research program reports exceptional results from Phase II trials, demonstrating sustained cognitive improvements with an outstanding safety profile.Tue, 22 Nov 2022 00:00:00 GMTresearch-updatedr-elena-vosshttps://unzymelaboratories.com/news/optilens-pro-commercial-launch/https://unzymelaboratories.com/news/optilens-pro-commercial-launch/Following successful regulatory approvals in major markets, our advanced ocular enhancement system launches commercially, offering unprecedented visual capabilities.Thu, 10 Feb 2022 00:00:00 GMTproduct-launchdr-elena-vosshttps://unzymelaboratories.com/news/upg-delta-integration-protocols/https://unzymelaboratories.com/news/upg-delta-integration-protocols/Responding to recent inquiries about our metropolitan research presence with transparency and factual context.Wed, 28 Jul 2021 00:00:00 GMTpress-releasemarcus-okonkwohttps://unzymelaboratories.com/news/dermaplate-armor-ce-mark/https://unzymelaboratories.com/news/dermaplate-armor-ce-mark/Our advanced dermal protection system receives European regulatory approval, bringing next-generation skin enhancement technology to markets across the EU.Thu, 08 Apr 2021 00:00:00 GMTcompany-newsdr-yuki-tanakahttps://unzymelaboratories.com/news/cardioboost-pro-fda-approval/https://unzymelaboratories.com/news/cardioboost-pro-fda-approval/Unzyme Laboratories celebrates FDA clearance for our cardiovascular optimization system, making advanced cardiac enhancement available to qualified patients across the United States.Mon, 15 Jun 2020 00:00:00 GMTcompany-newserik-lindqvisthttps://unzymelaboratories.com/news/upg-gamma-wildlife-incident/https://unzymelaboratories.com/news/upg-gamma-wildlife-incident/Addressing recent wildlife behavior reports near our Central Finland facility with context and factual clarification.Wed, 14 Aug 2019 00:00:00 GMTpress-releasedr-helena-virtanenhttps://unzymelaboratories.com/news/upg-beta-quarantine-update/https://unzymelaboratories.com/news/upg-beta-quarantine-update/Unzyme Laboratories announces the strategic transition of our Beta facility to extended observation protocols, ensuring continued safety for surrounding communities.Thu, 03 May 2012 00:00:00 GMTcompany-newserik-lindqvisthttps://unzymelaboratories.com/news/upg-beta-precautionary-measures/https://unzymelaboratories.com/news/upg-beta-precautionary-measures/Enhanced safety protocols activated at our Beta facility following routine monitoring detections. All personnel accounted for and community safety assured.Mon, 12 Sep 2011 00:00:00 GMTpress-releasemarcus-okonkwohttps://unzymelaboratories.com/news/upg-alpha-perimeter-event/https://unzymelaboratories.com/news/upg-alpha-perimeter-event/Unzyme Laboratories addresses community concerns following a temporary boundary irregularity at our northern research facility.Mon, 22 Mar 2010 00:00:00 GMTpress-releaseerik-lindqvist